Eileen Scully, MD, PhD

CRS:

JHU

Role:

Investigators

Position:

Investigator

Email:

escully1@jhmi.edu

Dr. Eileen Scully is an assistant professor of medicine at the Johns Hopkins University School of Medicine. 

She received her B.S. from the University of Notre Dame. She earned her Ph.D. and M.D. from Yale University. She completed her residency at Brigham and Women’s Hospital and performed a fellowship in infectious diseases at Massachusetts General Hospital.

  • Protocol Chair, ACTG A5366
  • Investigator, Women's Health Inter-Network Scientific Committee (Dec 2017-Nov 2019)

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5342: Evaluating the Safety, Tolerability, and Effect of a...

The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...

Read More

A5288: MULTIOCTAVE, Management Using the Latest Technologies...

The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...

Read More

A5324: A Randomized, Double-Blinded, Placebo-Controlled...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

Read More

A5302:  BioBank for Surrogate Marker Research for TB...

Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...

Read More

A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment...

A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...

Read More